By GlobeNewswire, October 21, 2013, 08:00:00 AM EDT
MIGDAL HA'EMEQ, Israel, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) today announced that it will release financial results for the third quarter ended September 30, 2013 on Monday, November 11, 2013, before the market opens. Following the release, the Company will host a conference call to discuss these results with additional comments and details. Participating on the call will be Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer.
The conference call is scheduled to begin at 8:30 a.m. ET on Monday, November 11, 2013. Listeners in North America may dial +1-646-254-3366 and international listeners may dial +44(0)20-3427-1914 along with confirmation code 7681511 to access the live call. A telephonic playback will be available after the call through Monday, November 25, 2013. Participants in North America may dial +1-347-366-9565 and international participants may dial +44(0)20-3427-0598 along with the confirmation code 7681511# to hear the playback.
The call will also be broadcast live over the Internet, hosted at the Investors section of Enzymotec's website at http://ir.enzymotec.com, and will be archived online within one hour of its completion through November 25, 2013.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies.
Source: Enzymotec Ltd.